Feature

Experity placing human connection at the center of AI-driven urgent care

Closely held Experity Health is shaping the future of healthcare by embedding AI into urgent care hubs across the U.S. to improve patient access, speed clinical visits, and elevate care quality.

November 11, 2025

Feature

QT Imaging redefining breast health diagnostics with advanced ultrasound technologies, AI/ML, and quantitative imaging biomarkers

QT Imaging Holdings (OTCQB: QTIH) is reshaping the breast imaging landscape through a convergence of quantitative ultrasound, artificial intelligence (AI), and biomarker science—delivering a safer, more accessible...

November 4, 2025

Feature

Immuneering outpacing cancer with a novel approach to improving overall survival

Immuneering (NASDAQ: IMRX) is challenging conventional approaches of sustained inhibition in oncology by pioneering a novel class of therapies designed to outsmart cancer’s ability to adapt. With a proprietary platform...

October 28, 2025

Feature

In conversation with Dr. Tyler Evans, co-founder, CEO and CMO of Wellness Equity Alliance

Tyler B. Evans, MD, MS, MPH, is a leading voice in global health equity, infectious disease, and humanitarian medicine. As co-founder, CEO, and chief medical officer of Wellness Equity Alliance (WEA), Dr. Evans has...

October 21, 2025

NEWS

PharmaJet inks agreement with EVA Pharma to provide needle-free injection systems to support routine polio immunization in Egypt

Cardiol to present comprehensive findings from Phase II ARCHER trial at ESC M&PD meeting

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

Experity placing human connection at the center of AI-driven urgent care

QT Imaging redefining breast health diagnostics with advanced ultrasound technologies, AI/ML, and quantitative imaging biomarkers

Immuneering outpacing cancer with a novel approach to improving overall survival

In conversation with Dr. Tyler Evans, co-founder, CEO and CMO of Wellness Equity Alliance

NEWS

Profound announces distribution agreement with Getz to bring TULSA-PRO to Australia and New Zealand

Profound inks distribution agreement for TULSA-PRO and Sonalleve with Al Faisaliah in Saudi Arabia

Precision presents late-breaking Phase 1 BDGENE-HBV data at AASLD

Cibus elects Craig Wichner to BOD

Altimmune’s Phase 2 IMPACT trial data published in The Lancet

Profound regains distribution rights for TULSA-PRO in Canada

Accomplished industry veteran, Satrajit Misra, joins QTI as CCO

PharmaJet inks agreement with EVA Pharma to provide needle-free injection systems to support routine polio immunization in Egypt

Cardiol to present comprehensive findings from Phase II ARCHER trial at ESC M&PD meeting

Just a few of the companies we’ve highlighted along the way

Subscribe